NORTH AMERICA GERD DRUGS AND DEVICES MARKET FORECAST 2019-2026

NORTH AMERICA GERD DRUGS AND DEVICES MARKET FORECAST 2019-2026

  • November 2018 •
  • 92 pages •
  • Report ID: 5626022 •
  • Format: PDF
KEY FINDINGS
The North American market for GERD drugs and devices is the largest in the world and is supposed to grow with a 0.78% CAGR for the forecast years 2019-2027. The United States of America and Canada are taken into consideration for the market analysis in this report.

MARKET INSIGHTS
The rise in initiatives for awareness, education and funding for research on reflux and GERD are helping to proliferate the GERD drugs and devices market in the United States.
Canada GERD drugs and devices market is the largest contributor in the North American region.This particular disorder is found to be the most commonly occurring acid levels fluctuation malady in Canada.

So, the level of raising awareness and preference of self-medication concerning GERD and other acid-related disorders are propelling the Canadian market growth.

COMPETITIVE INSIGHTS
Some of the key companies are focusing on newer products to increase their portfolio size are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. & Takeda Pharmaceuticals Company Ltd.

Companies mentioned
1. ABBOTT LABORATORIES.
2. ASTRAZENECA
3. BAUSCH HEALTH (FORMERLY VALEANT PHARMACEUTICALS INTERNATIONAL, INC.)
4. BOSTON SCIENTIFIC CORPORATION
5. CEMPRA INC. (MERGED WITH MELINTA)
6. DAEWOONG CO. LTD.
7. EISAI INC
8. GLAXOSMITHKLINE
9. IRONWOOD PHARMACEUTICALS, INC.
10. JOHNSON & JOHNSON
11. MERCK & CO., INC.
12. NOVARTIS
13. PFIZER, INC.
14. RAQUALIA PHARMA INC.
15. TAKEDA PHARMACEUTICALS COMPANY LIMITED